Stevanato Group (NYSE: STVN) announced its earnings guidance for fiscal year 2025 on Thursday, projecting an earnings per share (EPS) between 0.580 and 0.630. This estimate is slightly below the consensus EPS forecast of 0.610. Additionally, the company maintained its revenue guidance at $1.4 billion, aligning with market expectations.
Following the announcement, Stevanato’s stock experienced a decline of 2.7%, trading at €23.76 during Friday’s trading session. The trading volume reached 216,639 shares, notably lower than the average volume of 343,127 shares. Over the past fifty days, the stock has shown a simple moving average of €25.36, while the 200-day moving average stands at €24.19.
Stevanato Group currently holds a market capitalization of $7.19 billion and a price-to-earnings (P/E) ratio of 44.08. The firm also reports a debt-to-equity ratio of 0.25, a current ratio of 1.79, and a quick ratio of 1.22. Over the past year, the stock has fluctuated between a low of €17.49 and a high of €28.00.
Analyst Ratings and Investment Movements
In a separate report, Weiss Ratings reaffirmed a “hold (c)” rating on Stevanato Group’s shares. Analyst sentiment appears mixed, with one rating the stock as a Strong Buy, three issuing Buy ratings, and three assigning a Hold rating. According to data from MarketBeat.com, the overall consensus rating for the stock is classified as a “Moderate Buy.”
Recent institutional activity indicates fluctuating investor confidence. Notably, the State of Wyoming significantly increased its stake in Stevanato Group by an astonishing 39,216.7% during the second quarter, now holding 2,359 shares valued at approximately $58,000. Tower Research Capital LLC also raised its holdings by 1,268.7%, bringing its total to 4,585 shares worth about $112,000.
Other institutional investors have also made adjustments. Palisade Capital Management LP boosted its position by 5.8%, now owning 96,704 shares valued at $2,362,000. Orion Portfolio Solutions LLC increased its holdings by 2.8%, acquiring an additional 2,718 shares for a total value of $2,445,000. Lastly, Balyasny Asset Management L.P. expanded its stake by 6.3%, now owning 193,339 shares worth $4,723,000.
About Stevanato Group
Stevanato Group S.p.A. specializes in the design, production, and distribution of integrated solutions for the biopharma and healthcare sectors across multiple regions, including Europe, the Middle East, Africa, North America, South America, and the Asia Pacific. The company operates through two primary segments: Biopharmaceutical and Diagnostic Solutions, and Engineering.
The recent guidance and trading activity underscore the ongoing shifts in investor sentiment and market performance for Stevanato Group, highlighting the company’s strategic positioning within the healthcare landscape.
